Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2025

Oct 1, 2025

61176_rns_2025-10-01_99876b93-3b8d-4656-b77d-99347aadd595.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423

CIN: L24234KA1978PLC003417 www.biocon.com

BIO/SECL/EA/2025-26/99

October 01, 2025

October 01, 2025
To,The ManagerBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street, Mumbai – 400 001 To,The ManagerNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code – 532523 Scrip Symbol – BIOCON

Dear Sir/Madam,

Subject: Outcome of Board Meeting

Ref: Disclosure under Regulation 30 of the SEBI Listing Regulations, 2015

Further to our intimation dated September 28, 2025 under Regulation 29(1)(h) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations, 2015”), please be informed that the Board of Directors of the Company at its meeting held today i.e. on October 01, 2025, has approved the early full redemption of 1,07,000 (One Lakh Seven Thousand) unlisted, secured, rated, redeemable, Non-Convertible Debentures (NCDs) of face value of INR 1,00,000/- (Rupees One Lakh only) each, aggregating to Rs. 1,070 Crores (One Thousand and Seventy Crores only), issued and allotted by the Company on private placement basis on February 21, 2023.

Further, please be informed that the Company has made payment of due consideration today as per agreement with concerned debenture holders and the debenture trustee towards the aforesaid early full redemption of the NCDs.

The above information will also be available on the website of the Company at www.biocon.com.

The Board Meeting commenced at 6:30 P.M. (IST) and concluded at 6:48 P.M. (IST).

Kindly take the above information on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

RAJESH Digitally signed by RAJESH U U SHANOY Date: 2025.10.01 SHANOY 20:00:50 +05'30'


Rajesh U. Shanoy

Company Secretary and Compliance officer ICSI Membership Number: A16328